Loading news article.

Newsfiscal.ai

Gyre Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Nov 5, 2026, 17:32 ET · Published

Article summary

Gyre Therapeutics reported its third quarter 2026 financial results, including $32.9 million in revenue, and affirmed its full-year 2026 revenue guidance.

An excerpt from the original article.

Related companies

Gyre Therapeutics, Inc. Common StockGYREView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…